Globus Medical Announces CREO™ Modular Pedicle Screw Platform
Medical, Inc. (NYSE: GMED), a leading musculoskeletal
manufacturer, today announced that the company will be launching CREO™,
its next generation pedicle screw platform, at the North American...
Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal implant manufacturer, today announced that the company will be launching CREO™, its next generation pedicle screw platform, at the North American Spine Society (NASS) Annual Meeting being held October 9 -11 in New Orleans. “I am proud to announce the launch of CREO™, the most comprehensive and versatile pedicle screw system in the industry. CREO™ offers surgeons the ultimate in adaptability, with the ability to intraoperatively tailor the construct to best meet individual patients’ needs in treating complex spinal pathologies. Our most ambitious product launch to date, CREO’s™ streamlined, intuitively designed instrumentation facilitates efficient and reproducible outcomes,” commented Andrew Iott, Senior Vice President, Global Product Development. “This launch, focused on complex pathologies utilizing our patented non-threaded locking cap mechanism, represents the first phase in the evolution of the CREO™ Platform. The system will also include options for MIS (minimally invasive surgery), cortical screws, as well as a threaded locking cap version.” About CREO System The CREO™ and the CREO Advanced Modular Platform (AMP™) Stabilization Systems enhance efficiency and ease of use by providing intuitively designed instrumentation and intraoperative versatility along with a complete array of implant options for treating complex spinal pathologies, in one system. CREO™ pedicle screws are available in modular and pre-assembled versions with top-loading, side loading and closed head options. Rod diameters range from 4.75mm to 5.5mm and are available in titanium, cobalt chrome and stainless steel. The CREO™ and CREO AMP™ system will be on display at the North American Spine Society (NASS) Annual Meeting, being held October 9-11 in New Orleans, at the Globus Medical exhibit Booth #431. About Globus Medical, Inc.Globus Medical, Inc. is a leading musculoskeletal implant company based in Audubon, PA. The company was founded in 2003 by an experienced team of professionals with a shared vision to create products that enable surgeons to promote healing in patients with musculoskeletal disorders. Additional information can be accessed at www.globusmedical.com. Safe Harbor Statements All statements included in this press release other than statements of historical fact are forward-looking statements and may be identified by their use of words such as “believe,” “may,” “might,” “could,” “will,” “aim,” “estimate,” “continue,” “anticipate,” “intend,” “expect,” “plan” and other similar terms. These forward-looking statements are based on our current assumptions, expectations and estimates of future events and trends. Forward-looking statements are only predictions and are subject to many risks, uncertainties and other factors that may affect our businesses and operations and could cause actual results to differ materially from those predicted. These risks and uncertainties include, but are not limited to, factors affecting our quarterly results, our ability to manage our growth, our ability to sustain our profitability, demand for our products, our ability to compete successfully (including without limitation our ability to convince surgeons to use our products and our ability to attract and retain sales and other personnel), our ability to rapidly develop and introduce new products, our ability to develop and execute on successful business strategies, our ability to comply with changing laws and regulations that are applicable to our businesses, our ability to safeguard our intellectual property, our success in defending legal proceedings brought against us, trends in the medical device industry, general economic conditions, and other risks. For a discussion of these and other risks, uncertainties and other factors that could affect our results, you should refer to the disclosure contained in our most recent annual report on Form 10-K filed with the Securities and Exchange Commission, including the sections labeled “Risk Factors” and “Cautionary Note Concerning Forward-Looking Statements,” and in our Forms 10-Q, Forms 8-K and other filings with the Securities and Exchange Commission. These documents are available at www.sec.gov. Moreover, we operate in an evolving environment. New risk factors and uncertainties emerge from time to time and it is not possible for us to predict all risk factors and uncertainties, nor can we assess the impact of all factors on its business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements. Given these risks and uncertainties, readers are cautioned not to place undue reliance on any forward-looking statements. Forward-looking statements contained in this press release speak only as of the date of this press release. We undertake no obligation to update any forward-looking statements as a result of new information, events or circumstances or other factors arising or coming to our attention after the date hereof.